262 related articles for article (PubMed ID: 10504171)
1. Cancer vaccination.
Del Vecchio M; Parmiani G
Forum (Genova); 1999; 9(3):239-56. PubMed ID: 10504171
[TBL] [Abstract][Full Text] [Related]
2. Genetically modified tumour vaccines--where we are today.
Nawrocki S; Mackiewicz A
Cancer Treat Rev; 1999 Feb; 25(1):29-46. PubMed ID: 10212588
[TBL] [Abstract][Full Text] [Related]
3. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
[TBL] [Abstract][Full Text] [Related]
4. Cancer vaccines: an update with special focus on ganglioside antigens.
Bitton RJ; Guthmann MD; Gabri MR; Carnero AJ; Alonso DF; Fainboim L; Gomez DE
Oncol Rep; 2002; 9(2):267-76. PubMed ID: 11836591
[TBL] [Abstract][Full Text] [Related]
5. Human tumour antigens recognized by T cells: new perspectives for anti-cancer vaccines?
Coulie PG
Mol Med Today; 1997 Jun; 3(6):261-8. PubMed ID: 9211417
[TBL] [Abstract][Full Text] [Related]
6. Chaperone-rich cell lysates, immune activation and tumor vaccination.
Zeng Y; Graner MW; Katsanis E
Cancer Immunol Immunother; 2006 Mar; 55(3):329-38. PubMed ID: 15887013
[TBL] [Abstract][Full Text] [Related]
7. Tumor antigen-specific T helper cells in cancer immunity and immunotherapy.
Knutson KL; Disis ML
Cancer Immunol Immunother; 2005 Aug; 54(8):721-8. PubMed ID: 16010587
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cell vaccines for cancer therapy.
Sprinzl GM; Kacani L; Schrott-Fischer A; Romani N; Thumfart WF
Cancer Treat Rev; 2001 Aug; 27(4):247-55. PubMed ID: 11545544
[TBL] [Abstract][Full Text] [Related]
9. Melanoma vaccines: achievements and perspectives.
Brichard VG; Gérard C
Forum (Genova); 2003; 13(2):144-54; quiz 189. PubMed ID: 14732881
[TBL] [Abstract][Full Text] [Related]
10. [Cancer vaccines].
Kyte JA
Tidsskr Nor Laegeforen; 2006 Nov; 126(22):2969-73. PubMed ID: 17117197
[TBL] [Abstract][Full Text] [Related]
11. Clinical development of MVA-based therapeutic cancer vaccines.
Acres B; Bonnefoy JY
Expert Rev Vaccines; 2008 Sep; 7(7):889-93. PubMed ID: 18767940
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer vaccines.
Maxwell-Armstrong CA; Durrant LG; Scholefield JH
Br J Surg; 1998 Feb; 85(2):149-54. PubMed ID: 9501807
[TBL] [Abstract][Full Text] [Related]
13. Cancer vaccines: a step towards prevention and treatment of cancer.
Pandey M; Mathew A; Nair MK
Eur J Surg Oncol; 1999 Apr; 25(2):209-14. PubMed ID: 10218468
[TBL] [Abstract][Full Text] [Related]
14. Vaccines as early therapeutic interventions for cancer therapy: neutralising the immunosuppressive tumour environment and increasing T cell avidity may lead to improved responses.
Durrant LG; Pudney V; Spendlove I; Metheringham RL
Expert Opin Biol Ther; 2010 May; 10(5):735-48. PubMed ID: 20384522
[TBL] [Abstract][Full Text] [Related]
15. Cancer vaccines: challenges and outlook in the field.
Paul S; Acres B; Limacher JM; Bonnefoy JY
IDrugs; 2007 May; 10(5):324-8. PubMed ID: 17487784
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic cancer vaccines: using unique antigens.
Lewis JJ
Proc Natl Acad Sci U S A; 2004 Oct; 101 Suppl 2(Suppl 2):14653-6. PubMed ID: 15297620
[TBL] [Abstract][Full Text] [Related]
17. Antitumor vaccination: where we stand.
Bocchia M; Bronte V; Colombo MP; De Vincentiis A; Di Nicola M; Forni G; Lanata L; Lemoli RM; Massaia M; Rondelli D; Zanon P; Tura S
Haematologica; 2000 Nov; 85(11):1172-206. PubMed ID: 11074658
[TBL] [Abstract][Full Text] [Related]
18. Progress in human tumour immunology and immunotherapy.
Rosenberg SA
Nature; 2001 May; 411(6835):380-4. PubMed ID: 11357146
[TBL] [Abstract][Full Text] [Related]
19. Enhancing the clinical activity of granulocyte-macrophage colony-stimulating factor-secreting tumor cell vaccines.
Jinushi M; Hodi FS; Dranoff G
Immunol Rev; 2008 Apr; 222():287-98. PubMed ID: 18364009
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapeutic potential of whole tumour cells.
Ward S; Casey D; Labarthe MC; Whelan M; Dalgleish A; Pandha H; Todryk S
Cancer Immunol Immunother; 2002 Sep; 51(7):351-7. PubMed ID: 12192534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
